Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | SRPT | EXAS | ||
| Company | Acceleron Pharma | Sarepta Therapeutics | Exact Sciences Cor | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.85 | 120.21 | 58.21 | ||
| High | 179.85 | 122.18 | 58.95 | ||
| Low | 177.06 | 120.00 | 57.64 | ||
| Last | 178.75 | 121.90 | 58.11 | ||
| Change | -0.93 | +1.24 | -0.82 | ||
| % Change | -0.52% | +1.03% | -1.39% | ||
| Volume | 7,884,200 | 204,800 | 485,000 | ||
| 20-Day Average Volume | 1,302,050 | 1,003,545 | 2,097,455 | ||
| Previous Close | 179.68 | 120.66 | 58.93 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 125.99 | 60.83 | ||
| 20-Day Raw Stochastic | 84.01% | 26.67% | 26.97% | ||
| 20-Day Relative Strength | 70.12% | 48.68% | 46.06% | ||
| Weighted Alpha | +57.78 | +3.82 | -12.47 | ||
| Today's Opinion | 100% Buy | 72% Sell | 24% Sell | ||
| Previous Opinion | 100% Buy | 72% Sell | 8% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | -3.07% since 12/17/24 | -3.74% since 12/17/24 | ||
| Low | 173.17 on 11/16/21 | 117.39 on 12/23/24 | 55.65 on 12/19/24 | ||
| High | 179.94 on 11/17/21 | 126.04 on 12/18/24 | 60.62 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | +6.71% since 11/22/24 | +9.83% since 11/22/24 | ||
| Low | 172.25 on 10/20/21 | 113.00 on 11/25/24 | 52.81 on 11/25/24 | ||
| High | 179.94 on 11/17/21 | 138.81 on 11/29/24 | 64.77 on 12/05/24 | ||
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | -2.86% since 09/24/24 | -15.45% since 09/24/24 | ||
| Low | 120.20 on 08/20/21 | 102.15 on 11/18/24 | 48.02 on 11/12/24 | ||
| High | 189.99 on 09/29/21 | 138.81 on 11/29/24 | 72.83 on 11/05/24 | ||
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | -25.60% since 06/24/24 | +38.52% since 06/24/24 | ||
| Low | 113.49 on 07/15/21 | 102.15 on 11/18/24 | 40.62 on 06/25/24 | ||
| High | 189.99 on 09/29/21 | 164.52 on 06/25/24 | 72.83 on 11/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 11,525,442 | 10,906,529 | ||
| Shares Outstanding, K | 61,156 | 95,520 | 185,076 | ||
| Annual Sales | 92,520,000 | 1,243,340,000 | 2,499,770,000 | ||
| Annual Net Income | -166,030,000 | -535,980,000 | -204,150,000 | ||
| Last Quarter Sales | 34,200,000 | 467,170,000 | 708,660,000 | ||
| Last Quarter Net Income | -70,470,000 | 33,610,000 | -38,240,000 | ||
| 60-Month Beta | 0.13 | 0.77 | 1.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | 0.62 on 11/06/24 | -0.21 on 11/05/24 | ||
| Latest Earnings Date | 11/04/21 | 11/06/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 102.56 | 0.00 | ||